Targeting Pemphigus Autoantibodies through their Heavy-Chain Variable Region Genes

This publication has 44 references indexed in Scilit:

• Synergistic Pathogenic Effects of Combined Mouse Monoclonal Anti-Desmoglein 3 IgG Antibodies on Pemphigus Vulgaris Blister Formation
  Journal of Investigative Dermatology, 2006
• Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus
  British Journal of Dermatology, 2005
• In Vitro Keratinocyte Dissociation Assay for Evaluation of the Pathogenicity of Anti-Desmoglein 3 IgG Autoantibodies in Pemphigus Vulgaris
  Journal of Investigative Dermatology, 2005
• Desmosomes and disease: pemphigus and bullous impetigo
  Current Opinion in Cell Biology, 2004
• Long-term complete remission of severe pemphigus vulgaris with monoclonal anti-CD20 antibody therapy and immunophenotype correlations
  Journal of the American Academy of Dermatology, 2004
• Integrin αvβ3‐targeted therapy for Kaposi's sarcoma with an in vitro‐evolved antibody
  The FASEB Journal, 2002
• C-Cadherin Ectodomain Structure and Implications for Cell Adhesion Mechanisms
  Science, 2002
• Crystal structure of a phage library-derived single-chain fv fragment complexed with turkey egg-white lysozyme at 2.0 Å resolution 1 1Edited by I. A. Wilson
  Journal of Molecular Biology, 2000
• Crystal structure to 2.45 Å resolution of a monoclonal Fab specific for theBrucellaA cell wall polysaccharide antigen
  Protein Science, 1993
• Restricted immunoglobulin variable region gene usage by hybridoma rheumatoid factors from patients with systemic lupus erythematosus and rheumatoid arthritis
  Molecular Immunology, 1993